Catalyst Pharmaceuticals Earning Date (CPRX)

USA |NASDAQ |USD

CPRX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 8, 2022 Jun 2022 - - $0.11
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 8, 2022 Jun 2022 - - $36.37M

Catalyst Pharmaceuticals's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.

CPRX Earnings Date & History Chart

CPRX Earnings & Revenue Forecast

CPRX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $0.50 $0.44 $0.61

CPRX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 1 $0.56 $0.55 $0.43

CPRX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $164.18M $156.25M $175.71M

CPRX Earnings Date & Revenue History

CPRX Earnings History

|
Show More
Show More

CPRX Revenue History

|
Show More
Show More

Catalyst Pharmaceuticals Next Earnings Date & Report

CPRX Next Earnings Date & Report Preview: Jun 2022 (FQ)

CPRX's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.

Catalyst Pharmaceuticals Previous Earnings Dates & Reports

CPRX Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Catalyst Pharmaceuticals's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.

CPRX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Catalyst Pharmaceuticals's previous annual earnings date was Mar 15, 2021 for its fiscal year ended Dec 31, 2020.

CPRX's earnings per share (EPS) was $0.71, beating the consensus analysts forecast of $0.69 by 2.90% , and higher than the previous year's EPS (Dec 2019) by 144.83%.

Revenues were $119.07M, better than the forecast of $118.35M by 0.61%, and up by 16.39% from previous year's revenue.

The company reported a net income of $74.98M, 135.24% higher than the previous year.

Catalyst Pharmaceuticals reported a free cash flow of $45.02M for its fiscal year, compared to $34.59M a year ago.

The company ended the fiscal year with $28.77K in total debt, a decrease of -96.97% compared to the previous year.